Skip to main content

PUBLIC
BILL SUMMARY For HB25-1063

HOUSE COMMITTEE ON HEALTH & HUMAN SERVICES
Date Jan 14, 2025       Location HCR 0107

HB25-1063 - Referred to the Committee of the Whole


09:46:03 AM  
The primary bill sponsors, Representatives Hartsook and Brown, introduced House Bill 25-1063 to the House Health and Human Services Committee.The bill changes the definition of psilocybin in Schedule I to exempt prescription drug products containing crystalline polymorph psilocybin if such prescription drugs are approved by the U.S. Food and Drug Administration.
09:54:20 AM  
The bill sponsors responded to questions from the committee.
09:57:59 AM  
Tess Bettler, representing Compass Pathways, testified in support of the bill.
10:00:54 AM  
Ms. Bettler responded to questions from the committee.
10:03:06 AM  
Mr. Jimmy Smrz, representing themself, testified in opposition to the bill.
10:06:41 AM  
Mr. Smrz responded to questions from the committee.
10:11:47 AM  
John Armstrong - fiscal analyst, representing the Legislative Council Staff, responded to questions from members of the committee.
10:15:26 AM  
The primary bill sponsors provided closing comments on the bill.
10:18:29 AM  
Members of the committee provided closing comments on the bill.

10:22:55 AM
Motion Refer House Bill 25-1063 to the Committee of the Whole.
Moved Brown
Seconded Rydin
Bradfield Yes
Bradley No
Feret Yes
Gilchrist Yes
Hamrick Yes
Johnson Yes
Lukens Yes
McCormick Yes
Rydin Yes
Sander Yes
Stewart K. Yes
Lieder Yes
Brown Yes
Final YES: 12   NO: 1   EXC: 0   ABS:  0   FINAL ACTION:  PASS